HomeAI · summaries
Storia in 11 fonti
Moderna faz parceria com coalizão global de saúde para desenvolver vacina contra o Ebola Bundibugyo
Doença já registrou cerca de 900 casos suspeitos e mais de 220 mortes suspeitas
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
oglobo.globo.com
Ebola: por que o contágio é difícil e restrito?
Apesar de alerta de emergência internacional da OMS, cenário não apresenta potencial pandêmico devido a limitações na forma como o vírus é transmitido
- ·
União Africana alerta para mais de 1.100 casos suspeitos de ebola: 'Devemos agir na velocidade da epidemia'
Ministros da Saúde da República Democrática do Congo, de Uganda e do Sudão do Sul adotaram recentemente plano de resposta de US$ 319 milhões para enfrentar surto
- ·
morningstar.com
Moderna and CEPI Expand Strategic Collaboration to Advance Potential Vaccine Against Bundibugyo Ebolavirus
Coalition for Epidemic Preparedness Innovationsfunding builds on Moderna's prior filovirus research and supports preclinical development and Phase 1 clinical evaluation CAMBRIDGE,…
- ·
independent.co.uk
Moderna receives $50 million to develop Ebola vaccine as number of cases surge
This initiative is crucial as health authorities worldwide race to identify medical options and contain the outbreak, which has seen over 900 suspected cases and more than 220…
- ·
qz.com
Moderna partners with CEPI on Bundibugyo Ebola vaccine
CEPI is committing up to $50 million to support Moderna's vaccine candidate for the strain with no approved shot
- ·
koreatimes.co.kr
Moderna and other groups get $60 million to develop Ebola vaccine - The Korea Times
Global health organisation CEPI will give roughly $60 million to Moderna and to two other groups to accelerate the development of shots against Ebo...
- ·
g1.globo.com
Vacina contra ebola: Moderna desenvolve imunizante para cepa rara | G1
Parceria entre Moderna e CEPI foca em vacina contra a cepa Bundibugyo do ebola, enquanto a OMS prioriza imunizantes experimentais para conter surto no Congo.
- ·
Moderna faz parceria com coalizão global de saúde para desenvolver vacina contra o Ebola Bundibugyo
Doença já registrou cerca de 900 casos suspeitos e mais de 220 mortes suspeitas
- ·
sueddeutsche.de
Moderna entwickelt Impfstoff gegen Ebola-Variante
Der US-Pharmakonzern will mit Unterstützung der internationalen Impfallianz CEPI einen Impfstoff gegen das Bundibugyo-Ebolavirus herstellen. Diese Ebola-Variante verbreitet sich…
- ·
arabnews.com
Moderna and other groups get $60m to develop Ebola vaccine
BENGALURU: Global health organization CEPI will give roughly $60 million to Moderna and to two other groups to accelerate the development of shots against Ebola Bundibugyo, the…
- ·
arstechnica.com
Moderna gets $50 million to develop mRNA Ebola vaccine against Bundibugyo
Amid a raging Ebola outbreak, officials "urgently accelerate development" of vaccines.
- ·
valor.globo.com
Três grupos recebem US$ 60 milhões para desenvolver vacina contra ebola
Moderna, Serum Institute of India com Universidade de Oxford, e coalizão mundial para vacina contra Aids Iavi ganham fundos; Moderna recebe US$ 50 milhões
- ·
thejakartapost.com
Moderna and other groups get $60 million to develop Ebola vaccine - Middle East and Africa - The Jakarta Post
The Coalition for Epidemic Preparedness Innovations was one of the early investors that helped to develop a vaccine at the height of the COVID-19 pandemic.